Logo
JNJ logo
Johnson & Johnson
JNJ
195.93 (0.75%) 1.47
Health Care
Pharmaceuticals
Johnson & Johnson together with its subsidiaries engages in the research and development manufacture and sale of various products in the healthcare field worldwide. It operates in two segments Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas such as immunology including rheumatoid arthritis psoriatic arthritis inflammatory bowel disease and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience consisting of mood disorders neurodegenerative disorders and schizophrenia; oncology such as prostate cancer hematologic malignancies lung cancer and bladder cancer; cardiovascular and metabolism including thrombosis diabetes and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers wholesalers distributors hospitals and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips knees trauma spine sports and other; surgery portfolios comprising advanced and general surgery technologies as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers hospitals and retailers as well as physicians nurses hospitals eye care professionals and clinics. The company was founded in 1886 and is based in New Brunswick New Jersey.

Quality Checklist 6/8

5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio

My holdings

Day change:
Total change:
Shares:
Cost basis:
Market cap: $472.05(B)
EV: $503.93(B)
Total Equity: $79.28(B)
Earnings date: Jan-21-2026
P/E: 18.79
Forward P/E: 18.04
P/FCF: 24.07
P/S: 5.12
P/B: 5.95
EPS: $10.4
EPS (fwd): $10.9
FCF/share: $8.1
Revenue/share: $38.3
Book value/share: $33.0
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.58
Current Ratio: 1.10
Gross margin: 68.3%
Operating margin: 26.2%
Net margin: 27.3%
Dividend/share: $5.1
Div. yield: 2.59%
All Valuation Overview Growth Financials & KPIsCompetitors & Peer Comparison Ownership Tools

Ownership

Major holders

*Excludes indirect insider ownership

Insiders: 0.06%
Institutions: 74.85%
Other: 25.09%

Institutional ownership

9.82% Vanguard Group Inc8.60% Blackrock Inc.5.51% State Street Corporati...2.43% JPMORGAN CHASE & CO2.33% Geode Capital Manageme...1.95% Morgan Stanley1.33% NORGES BANK1.31% State Farm Mutual Auto...1.26% Northern Trust Corpora...1.14% Bank of America Corpor...39.17% Others

Trading Summary

In the past year, insiders have bought $147220 worth of the company's stock, and sold $46.11(M).

Congress members have bought between $71029 - $540000 worth of the company's stock, and sold between $323020 - $995000.

Insider transactions

$0.002025-12$0.00
$0.002025-11$0.00
$4.19(M)2025-10$0.00
$10.04(M)2025-09$0.00
$25.52(M)2025-08$0.00
$3.13(M)2025-07$0.00
$0.002025-06$0.00
$0.002025-05$0.00
$0.002025-04$0.00
$0.002025-03$0.00
$3.23(M)2025-02$0.00
$0.002025-01$0.00
$0.002024-12$147220
DateSharesTotal ($)Price ($)NameTitle
Grant2025-10-1721,7213,430,180157.9REED JOHN COfficer
Sell2025-10-1721,7214,185,793192.7REED JOHN COfficer
Grant2025-09-0456,4715,752,701101.9TAUBERT JENNIFER LOfficer
Sell2025-09-0456,47110,040,883177.8TAUBERT JENNIFER LOfficer
Grant2025-08-2911,5211,332,634115.7FORMINARD ELIZABETHGeneral Counsel
Grant2025-08-22125,82412,817,691101.9DUATO JOAQUIN BOIXChief Executive Officer
Sell2025-08-22125,82422,548,655179.2DUATO JOAQUIN BOIXChief Executive Officer
Grant2025-08-1516,8201,713,453101.9WOLK JOSEPH JChief Financial Officer
Sell2025-08-1516,8202,975,571176.9WOLK JOSEPH JChief Financial Officer
Sell2025-07-1719,1373,129,830163.5REED JOHN COfficer
Grant2025-03-18130,85200.0DUATO JOAQUIN BOIXChief Executive Officer
Grant2025-02-256,999712,988101.9DECKER ROBERT JOfficer
Sell2025-02-256,9991,160,994165.9DECKER ROBERT JOfficer
Sell2025-02-1840362,928156.1SCHMID TIMOTHYOfficer
Grant2025-02-0713,0151,302,281100.1WOLK JOSEPH JChief Financial Officer
Grant2025-02-07126,36912,644,482100.1DUATO JOAQUIN BOIXChief Executive Officer
Grant2025-02-0732,7623,278,166100.1WENGEL KATHRYN EChief Operating Officer
Grant2025-02-0758,5045,853,910100.1TAUBERT JENNIFER LOfficer
Sell2025-02-0713,0152,002,878153.9WOLK JOSEPH JChief Financial Officer
Buy2024-12-121,000147,220147.2WEINBERGER MARK ADirector

Congressional trading

$0.002025-12$0.00
$0.002025-11$0.00
$0.002025-10$0.00
$0.002025-09$0.00
$0.002025-08$0.00
$0.002025-07$0.00
$1135032025-06$8001
$910022025-05$64503
$400032025-04$24002
$1830012025-03$81002
$0.002025-02$0.00
$240022025-01$56004
$1750012024-12$32002
DatePoliticianPartyChamberAmount ($)
Sell2025-06-23Ro KhannaDHouse$15,001 - $50,000
Sell2025-06-20Ro KhannaDHouse$1,001 - $15,000
Sell2025-06-20Ro KhannaDHouse$1,001 - $15,000
Sell2025-06-16Scott FranklinRHouse$15,001 - $50,000
Sell2025-06-12Pete SessionsRHouse$15,001 - $50,000
Buy2025-06-10Lloyd DoggettDHouse$1,001 - $15,000
Buy2025-05-30Gilbert Ray Cisneros, Jr.DHouse$15,001 - $50,000
Sell2025-05-28Ro KhannaDHouse$1,001 - $15,000
Sell2025-05-19Ro KhannaDHouse$1,001 - $15,000
Sell2025-05-12Jefferson ShreveRHouse$50,001 - $100,000
Buy2025-05-09Ro KhannaDHouse$1,001 - $15,000
Buy2025-05-09Ro KhannaDHouse$1,001 - $15,000
Buy2025-05-09Ro KhannaDHouse$1,001 - $15,000
Buy2025-05-05Marjorie Taylor GreeneRHouse$1,001 - $15,000
Sell2025-04-29Gilbert Ray Cisneros, Jr.DHouse$1,001 - $15,000
Sell2025-04-21Bruce WestermanRHouse$1,001 - $15,000
Sell2025-04-09Josh GottheimerDHouse$1,001 - $15,000
Sell2025-04-08Rob BresnahanRHouse$1,001 - $15,000
Buy2025-04-04Ro KhannaDHouse$1,001 - $15,000
Buy2025-04-04Ro KhannaDHouse$1,001 - $15,000
Buy2025-04-04Ro KhannaDHouse$1,001 - $15,000
Sell2025-04-01Julie JohnsonDHouse$1,001 - $15,000
Buy2025-03-31Gilbert Ray Cisneros, Jr.DHouse$15,001 - $50,000
Sell2025-03-24George WhitesidesDHouse$100,001 - $250,000
Sell2025-03-07Josh GottheimerDHouse$1,001 - $15,000
Buy2025-03-05Jefferson ShreveRHouse$15,001 - $50,000
Buy2025-03-04Lloyd DoggettDHouse$1,001 - $15,000
Buy2025-03-03Bruce WestermanRHouse$1,001 - $15,000
Buy2025-01-24Josh GottheimerDHouse$1,001 - $15,000
Sell2025-01-24Gilbert Ray Cisneros, Jr.DHouse$1,001 - $15,000
Sell2025-01-22Ro KhannaDHouse$1,001 - $15,000
Sell2025-01-22Ro KhannaDHouse$1,001 - $15,000
Buy2025-01-21Josh GottheimerDHouse$1,001 - $15,000
Buy2025-01-17Ro KhannaDHouse$1,001 - $15,000
Buy2025-01-16Josh GottheimerDHouse$1,001 - $15,000
Buy2025-01-08Marjorie Taylor GreeneRHouse$1,001 - $15,000
Buy2025-01-08Marjorie Taylor GreeneRHouse$1,001 - $15,000
Buy2025-01-08Marjorie Taylor GreeneRHouse$1,001 - $15,000
Sell2024-12-31Kevin HernRHouse$100,001 - $250,000
Buy2024-12-24Marjorie Taylor GreeneRHouse$1,001 - $15,000
Buy2024-12-12Josh GottheimerDHouse$1,001 - $15,000
Buy2024-12-10Lloyd DoggettDHouse$1,001 - $15,000
Buy2024-12-06Virginia FoxxRHouse$1,001 - $15,000
Buy2024-11-26Josh GottheimerDHouse$1,001 - $15,000
Buy2024-11-25Marjorie Taylor GreeneRHouse$1,001 - $15,000
Buy2024-11-22Josh GottheimerDHouse$1,001 - $15,000
Buy2024-11-15Ro KhannaDHouse$1,001 - $15,000
Buy2024-11-08Jared MoskowitzDHouse$1,001 - $15,000
Sell2024-10-29Tommy TubervilleRSenate$15,001 - $50,000
(C) PEVALUATOR
About
Terms & privacy
Price charts & news courtesy of TradingView
Blog
Contact